FDA – Drug Supply Chain Security


iulia@plus972group.com
FDA – Drug Supply Chain Security

The FDA has recently finalized some regulations regarding the Drug Supply Chain Security Act (DSCSA). The goal is to help companies that operate in the pharmaceutical industry understand the new methods that will be adopted in order to comply with product chain and distribution legislation regarding the electronic identification of products.

The new mechanism will allow the FDA to protect consumers from purchasing pharmaceutical products that are counterfeit, stolen, contaminated or dangerous.

With a few exceptions, the pharmaceutical products must be equipped with the new, electronic identification by November 27, 2018.

The information provided here does not, and is not intended to, constitute legal advice but simply information for general purposes only and may not be the most up to date. Use of our website or any of its links or resources do not create an attorney-client relationship between the reader, user, or browser and the law firm. The views expressed at, or through, this site are those of the individual authors writing in their individual capacities only.

Show Comments (0)

Comments